The ABC of BioTech startup funding
Read tips from Michael Salako, Start Codon Investment Director.
Biotech startups often require substantial initial capital to support extensive research and development, clinical trials, and regulatory approvals before generating any revenue.
Start Codon Investment Director, Michael Salako PhD MBA, recently spoke to Labiotech.eu, offering his advice to biotech startups trying to navigate the complex funding landscape.
When tackling the VC landscape, Michael advises biotech startups to be cautious and organised. “They should have a light touch non-confidential deck to send out and set the scene and a longer, more technical non-confidential deck that they can quickly talk to on a call if afforded the chance."
For more practical advice on choosing the right approach, read Michael's full blog post here: https://rb.gy/smbt2h